Collegium Pharmaceutical, Inc. Common Stock
COLL Real Time Price USDRecent trades of COLL by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by COLL's directors and management
Government lobbying spending instances
-
$10,000 Jan 16, 2025 Issue: Health Issues
-
$10,000 Oct 17, 2024 Issue: Health Issues
-
$10,000 Jul 15, 2024 Issue: Health Issues
-
$10,000 Apr 17, 2024 Issue: Health Issues
-
$10,000 Oct 20, 2023 Issue: Health Issues
-
$10,000 Jul 20, 2023 Issue: Health Issues
-
$60,000 Jan 19, 2022 Issue: Health Issues
-
$60,000 Oct 20, 2021 Issue: Health Issues
-
$60,000 Jul 20, 2021 Issue: Health Issues
-
$10,000 Apr 20, 2017 Issue: Health Issues
-
$20,000 Jan 23, 2017 Issue: Health Issues
-
$30,000 Oct 14, 2016 Issue: Health Issues
-
$40,000 Jul 19, 2016 Issue: Health Issues
-
$10,000 Apr 20, 2016 Issue: Health Issues
Estimated quarterly lobbying spending
COLL Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to COLL
Number of mentions of COLL in WallStreetBets Daily Discussion
Recent picks made for COLL stock on CNBC
ETFs with the largest estimated holdings in COLL
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $COLL stock a Buy, Sell, or Hold?
- What is the price target for $COLL stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $COLL stock?
- Who owns the most shares of $COLL stock?
- What funds own $COLL stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view COLL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.